Minggu, 29 April 2012

Levaquin Approved For Treating Plague, USA

Levaquin Approved For Treating Plague, USA

Editor's Choice
Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Bio-terrorism / Terrorism;  Regulatory Affairs / Drug Approvals
Article Date: 29 Apr 2012 - 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article



Patient / Public:1 star

1 (1 votes)

Healthcare Prof:3 stars

3 (2 votes)


Levaquin (levofloxacin) has been approved by the FDA for the treatment and prevention of the plague. Levofloxacin is a synthetic antibiotic of the fluoroquinolones drug class; it is currently used for the treatment of severe bacterial infection, or infections for which other antibiotics have not worked.

Levaquin is produced and marketed by Janssen Pharmaceuticals Inc., a Johnson Johnson company.

The FDA has also approved Levaquin to lower the chances of contracting the plague after exposure to Yersinia pestis.

Yersinia pestis and plagues in human history

Yersinia pestis, previously known as Pasteurella pestis, is a bacterium which can infect humans and many animals.

Infection can take three forms:

  • septicemic
  • pneumonic
  • the infamous bubonic plagues
Scientists and historians say that Yersinia pestis has been responsible for many epidemics in human history in which mortality was extremely high. Examples include the Black Death, which is said to have wiped out one third of Europe's human population between 1347 and 1353. The bacterium was most likely also involved in the Plague of Justinian in AD 542.

Yersinia pestis and the terrorist threat


Xenopsylla cheopis, the Oriental Rat Flea. The Yersinia pestis bacterium appears as a dark mass in the gut. Such fleas have the potential to infect humans Scientists today fear that Yersinia pestis could be used in terrorist attacks. In fact, the Centers for Disease Control and Prevention (CDC), USA, classifies Yersinia pestis as a Category A pathogen, and says preparations should be made for possible terrorist attacks.

Yersinia pestis very rare today

Despite its devastating history, the bacterium is extremely rare today. According to WHO (World Health Organization), there are approximately 1,000 to 2,000 reported cases of human infection annually worldwide.

Testing Levaquin's efficacy in preventing and treating Yersinia pestis exposure was done on African Green monkeys. For ethical reasons, human trials were not possible.

The following drugs are now FDA approved for the treatment and/or prevention of plague:

  • Levaquin (levofloxacin)
  • Streptomycin
  • Doxycycline
  • Tetracycline
According to the Wall Street Journal, Johnson Johnson shares rose 22 cents on Friday to $64.79.

Written by Christian Nordqvist


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Levaquin Approved For Treating Plague, USA'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.

Everyday Health Network

Tidak ada komentar:

Posting Komentar